ADAPTIMMUNE THERAPEUTICS PLC Research and Development Asset Acquired Other than Through Business Combination, Written-off
ADAPTIMMUNE THERAPEUTICS PLC (ADAPY) reported Research and Development Asset Acquired Other than Through Business Combination, Written-off of $52.00 thousand for the 12-month period ending 2024-12-31, per its 10-K filed 2025-03-24.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:ResearchAndDevelopmentAssetAcquiredOtherThanThroughBusinessCombinationWrittenOff · last filed 2025-03-24
- ADAPTIMMUNE THERAPEUTICS PLC research and development asset acquired other than through business combination, written-off for fiscal 2024 was $52.00K, a 97.17% decline from fiscal 2023.
- ADAPTIMMUNE THERAPEUTICS PLC research and development asset acquired other than through business combination, written-off for fiscal 2023 was $1.84M, a 20.55% decline from fiscal 2022.
- ADAPTIMMUNE THERAPEUTICS PLC research and development asset acquired other than through business combination, written-off for fiscal 2022 was $2.32M, a 160.52% increase from fiscal 2021.
- ADAPTIMMUNE THERAPEUTICS PLC research and development asset acquired other than through business combination, written-off for fiscal 2021 was $889.00K, a 0.00% change from fiscal 2020.
| Period end | Research and Development Asset Acquired Other than Through Business Combination, Written-off 6 month | Research and Development Asset Acquired Other than Through Business Combination, Written-off 12 month | Research and Development Asset Acquired Other than Through Business Combination, Written-off 12 month as first filed |
|---|---|---|---|
| 2024-12-31 | $52.00K 10-K · filed 2025-03-24 | ||
| 2023-12-31 | $1.84M 10-K · filed 2024-03-06 | ||
| 2022-12-31 | $2.32M 10-K · filed 2025-03-24 | ||
| 2021-12-31 | $889.00K 10-K · filed 2024-03-06 | $562.00K 10-K · filed 2022-03-14 | |
| 2020-12-31 | $889.00K 10-K · filed 2023-03-06 | ||
| 2019-12-31 | $4.56M 10-K · filed 2022-03-14 | ||
| 2018-12-31 | $210.00K 10-K · filed 2021-02-25 | ||
| 2017-12-31 | $1.00M 10-K · filed 2019-02-27 | ||
| 2016-12-31 | $3.00M 10-K · filed 2019-02-27 | ||
| 2015-12-31 | $2.50M 10-K · filed 2018-03-15 | ||
| 2015-06-30 | $0.00 10-K · filed 2018-03-15 | ||
| 2014-06-30 | $0.00 10-K · filed 2017-03-13 |